Jeffrey M. Grassi

874 total citations
16 papers, 735 citations indexed

About

Jeffrey M. Grassi is a scholar working on Pharmacology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jeffrey M. Grassi has authored 16 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jeffrey M. Grassi's work include Pharmacogenetics and Drug Metabolism (8 papers), Pharmacology and Obesity Treatment (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jeffrey M. Grassi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Pharmacology and Obesity Treatment (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jeffrey M. Grassi collaborates with scholars based in United States. Jeffrey M. Grassi's co-authors include Richard I. Shader, Brian Granda, David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz, Su Duan, Karthik Venkatakrishnan, Steven M. Fogelman, Johanna P. Daily and J S Harmatz and has published in prestigious journals such as Biological Psychiatry, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeffrey M. Grassi

16 papers receiving 708 citations

Peers

Countries citing papers authored by Jeffrey M. Grassi

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Grassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Grassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Grassi more than expected).

Fields of papers citing papers by Jeffrey M. Grassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Grassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Grassi. The network helps show where Jeffrey M. Grassi may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Grassi

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Grassi. A scholar is included among the top collaborators of Jeffrey M. Grassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Grassi. Jeffrey M. Grassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Novel, Acidic CCR2 Receptor Antagonists: From Hit to Lead 2007 ·Letters in Drug Design & Discovery ·(unknown), (unknown), Joseph Eckman, Paul J. Higgins, Michel Gillard, Laurent Knerr, Stéphane Carré, Patrick Pasau, Philippe Collart, Jeffrey M. Grassi	14
2	Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses 2006 ·Pharmacology Biochemistry and Behavior ·Jeanne M. Fahey, Jeffrey M. Grassi, (unknown), David J. Greenblatt	15
3	The effect of chronic lorazepam administration in aging mice 2006 ·Brain Research ·Jeanne M. Fahey, Gary A. Pritchard, (unknown), (unknown), Jeffrey M. Grassi, Richard I. Shader, David J. Greenblatt	7
4	INTERACTION OF TRIAZOLAM AND KETOCONAZOLE IN P-GLYCOPROTEIN-DEFICIENT MICE 2004 ·Drug Metabolism and Disposition ·Lisa L. von Moltke, Brian Granda, Jeffrey M. Grassi, Michael Perloff, Daesety Vishnuvardhan, David J. Greenblatt	30
5	Pharmacodynamic and receptor binding changes during chronic lorazepam administration 2001 ·Pharmacology Biochemistry and Behavior ·Jeanne M. Fahey, Gary A. Pritchard, Jeffrey M. Grassi, (unknown), Richard I. Shader, David J. Greenblatt	22
6	Use of high-performance LC packings from pH 1 to pH 12 1999 ·Uwe D. Neue, Thomas H. Walter, Bonnie A. Alden, Zhiping Jiang, Raymond P. Fisk, (unknown), (unknown), (unknown), Jeffrey M. Grassi, Yung‐Fong Cheng, Ziling Lu, (unknown)	30
7	Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects 1999 ·Biological Psychiatry ·Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi, Brian Granda, Karthik Venkatakrishnan, Su Duan, Steven M. Fogelman, Jerold S. Harmatz, Richard I. Shader	75
8	Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations 1999 ·British Journal of Clinical Pharmacology ·Lisa L. von Moltke, David J. Greenblatt, Brian Granda, Su Duan, Jeffrey M. Grassi, Karthik Venkatakrishnan, J S Harmatz, Richard I. Shader	105
9	Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions 1999 ·Psychopharmacology ·Lisa L. von Moltke, David J. Greenblatt, Brian Granda, Jeffrey M. Grassi, (unknown), Jerold S. Harmatz, Richard I. Shader	65
10	Multiple site interaction of triazolam and ketoconazole in mice: Role of P-glycoprotein 1999 ·Clinical Pharmacology & Therapeutics ·L VONMOLTKE, Brian Granda, Jeffrey M. Grassi, D J Greenblatt	4
11	In situ hybridization histochemistry as a method to assess GABAAreceptor subunit mRNA expression following chronic alprazolam administration 1999 ·Journal of Psychopharmacology ·Jeanne M. Fahey, Gary A. Pritchard, Jeffrey M. Grassi, (unknown), Richard I. Shader, David J. Greenblatt	7
12	Effects of Ketoconazole on Triazolam Pharmacokinetics, Pharmacodynamics and Benzodiazepine Receptor Binding in Mice 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Jeanne M. Fahey, Gary A. Pritchard, Lisa L. von Moltke, (unknown), Jeffrey M. Grassi, Richard I. Shader, David J. Greenblatt	31
13	Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects 1998 ·Psychopharmacology ·Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi, Brian Granda, Steven M. Fogelman, Jerold S. Harmatz, (unknown), Louis F. Fabre, Richard I. Shader	16
14	Appetite Suppressant Drugs as Inhibitors of Human Cytochromes P450 1998 ·Journal of Clinical Psychopharmacology ·Lisa L. von Moltke, David J. Greenblatt, Domenic A. Ciraulo, Jeffrey M. Grassi, Brian Granda, Su Duan, J S Harmatz, Richard I. Shader	12
15	Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir 1998 ·The Journal of Clinical Pharmacology ·Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi, Brian Granda, Su Duan, Steven M. Fogelman, Johanna P. Daily, Jerold S. Harmatz, Richard I. Shader	209
16	Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A 1998 ·Journal of Pharmacy and Pharmacology ·Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi, Brian Granda, Karthik Venkatakrishnan, Jürgen Schmider, Jerold S. Harmatz, Richard I. Shader	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact